Convatec scores 39/100 (Below expectations) on SINK's independent climate assessment — scored from public data only, no company payment can change a number. Last verified August 2026.
That places Convatec joint 366th of 790 companies scored, and joint 12th of 15 in Healthcare / Pharmaceuticals.
Convatec has achieved credible operational carbon reductions (62% Scope 1+2 by 2024) backed by SBTi validation, but Scope 3—representing 94% of footprint—targets intensity, not absolute cuts. Water and biodiversity impacts are identified but unquantified. Transparency is strong; controversies absent.
Every supplier scored from public evidence like this, ranked, in 48 hours. No questionnaires, and your suppliers never know.
This score uses public evidence only. Challenge any question for free, or ask for a human review of evidence you haven't published.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleStrongest on Controversies & Red Flags and Carbon Footprint — Operations (8/10, 7/10). Weakest on Water Impact and Nature & Biodiversity Impact (4/10, 4/10).
10 sources used in this assessment. All publicly available. Each row shows which rubric questions it informed.
“In 2024, we reduced our Scope 1 and 2 GHG emissions by 14% against our 2023 emissions”
“2024 Independent assurance report PDF · ESG Basis of reporting FY24 PDF”
“In 2024, we reached 62% reduction against the baseline, achieved through improved energy efficiency, retrofits, smart metering”
“screening exercise during 2022 to determine which of the Scope 3 categories are most significant”
“Science Based Target, which was validated in 2023”
“B-rating from the Carbon Disclosure Project (CDP) and a Silver award from EcoVadis in their 2024 ratings”
“reducing Scope 1 and 2 greenhouse gas emissions by 6.9% and procuring over 99% of its electricity from renewable sources globally”
“The SBTi's Target Dashboard lists companies and financial institutions that have set science-based targets, or have committed to developing targets.”
“the majority of industrial companies in sectors like retail and healthcare not strategically involved in climate policy”
“In 2023, ConvaTec was included in the 'Leave Russia' project, which tracks companies that remain active in the Russian market”
If you believe a source has been misread or a newer version exists, submit a challenge.
Convatec is tied at the bottom of the healthcare / pharmaceuticals pack.
Among the 15 major healthcare / pharmaceuticals brands we've scored, Convatec is tied =12th of 15, with 3 others.
As Convatec's score updates, the trajectory will appear here.
This score is not currently being contested.
Every challenge is published. We'd rather be corrected than wrong — that's the whole point.
No challenges submitted yet. If you have evidence that contradicts this score, you can challenge any question above — cite a public source and we'll review it.
Convatec is a Reading-based medical device manufacturer specializing in ostomy care, continence and infusion therapies, and wound care. Founded 1978, listed on NASDAQ. Operates global manufacturing and distribution networks serving healthcare systems and patients across 100+ countries.
Direct healthcare competitor; pharmaceutical and medical device manufacturer with global operations.
View breakdown →Healthcare peer; wound care and orthopedic device manufacturer; comparable supply chain complexity.
View breakdown →Pharma/diagnostics conglomerate; larger scale; relevant for SBTi validation and emissions reporting comparison.
View breakdown →Consumer healthcare exposure through brands; larger, longer ESG disclosure track record across supply chain.
View breakdown →Email alerts when a rubric question is verified, a challenge is resolved, or the overall score changes.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Checking your suppliers?
Get your list scored in 48 hours →Been scored?
See what's behind your number →Nobody can pay us to change a number.